IL1B and colitis: Little change in colonic B cells was observed after IL-1β blockade in Fcgr2b−/− mice (Figure S6J); however, there was a reduction in the severity of colitis (Figure 6H) and colonic neutrophil infiltration (Figure 6I), directly implicating this pathway in detrimental immune responses driven by dysregulated FcγR signaling.